Is conservative treatment of HELLP syndrome safe?

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 80, Issue 2, 1998, Pages 139-141

  Tsatsaris, V ^a   Carbonne, B ^a   Dupre La Tour M ^b   Cabrol, D ^b   Milliez, J ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b Maternite Port Royal Baudelocque ^*  (France)

Author keywords

Abruptio placentae; Corticosteroids; HELLP syndrome

Indexed keywords

BETAMETHASONE; DEXAMETHASONE; NICARDIPINE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HELLP SYNDROME; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA; SOLUTIO PLACENTAE; THROMBOCYTE COUNT;

EID: 0032189219     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(98)00108-0     Document Type: Article

References (16)

1. [1] Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982;142:159-67.
2. [2] Barton JR, Sibai BM. Care of the pregnancy complicated by HELLP syndrome. Obstet Gynecol Clin North Am 1991;18:165-79.
3. [3] Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993;169:1000-6.
4. [4] Schröder W, Heyl W. HELLP syndrome: difficulties in diagnosis and therapy of a severe form of pre-eclampsia. Clin Exp Obstet Gynecol 1990;20:88-94.
5. [5] Sibai BM, Taslimi MM, El-Nazer A, Amon E, Mabie BC, Ryan GM. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes and low platelets in severe pre-eclampsia-eclampsia. Am J Obstet Gynecol 1986;155:501-9.
6. [6] Magann EF, Washburne JF, Sullivan CA, Chauhan SP, Morrison JC, Martin Jr. JN. Corticosteroid-induced arrest of HELLP syndrome progression in a marginally-viable pregnancy. Eur J Obstet Gynecol Biol Reprod 1995;59:217-9.
7. [7] Thiagarajah S, Bourgeois FJ, Harbert Jr. GM, Caudle MR. Thrombocytopenia in pre-eclampsia: associated abnormalities and management principles. Am J Obstet Gynecol 1984;150:1-7.
8. [8] Magann EF, Graves GR, Roberts WE, Blake PG, Morrison JC, Martin Jr. JN. Corticosteroids for enhanced fetal lung maturation in patients with HELLP syndrome: impact on neonates. Aust NZ J Obstet Gynaecol 1993;33:131-5.
9. [9] Magann EF, Martin RW, Isaacs JD, Blake PG, Morrison JC, Martin Jr. JN. Corticosteroids for enhanced fetal lung maturity: impact on the gravida with preeclampsia and the HELLP syndrome. Aust NZ J Obstet Gynaecol 1993;33:127-31.
10. [10] Carbonne B, Jannet D, Touboul C, Khelifati Y, Milliez J. Nicardipine treatment of hypertension during pregnancy. Obstet Gynecol 1993;81:908-14.
11. [11] Audibert F, Friedman SA, Frangieh AY, Sibai BM. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome. Am J Obstet Gynecol 1996;175:460-4.
12. [12] Martin Jr. JN, Blake PG, Lowry SL, Perry Jr. KG, Files JC, Morrison JC. Pregnancy complicated by pre-eclampsia-eclampsia with the syndrome of hemolysis, elevated liver enzymes and low platelet count: how rapid is the post-partum recovery?. Obstet Gynecol 1990;76:737-41.
13. [13] Magann EF, Bass D, Chauhan SP, Sullivan DL, Martin RW, Martin Jr. JN. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes and low platelets. Am J Obstet Gynecol 1994;171:1148-53.
14. [14] Visser W, Wallenburg HC. Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 1995;102:111-7.
15. [15] Harms K, Rath W, Herting E, Kuhn W. Maternal hemolysis, elevated liver enzymes, low platelet count and neonatal outcome. Am J Perinatol 1995;12:1-6.
16. [16] Dawes GS, Serra-Serra V, Moulden M, Redman CW. Dexamethasone and fetal heart rate variation. Br J Obstet Gynaecol 1994;101:675-9.